Alzheimer’s Foundation of America

No. 429: Classic cartoons, downtown dreams and the nitrogen nuisance – plus, it curves!

  Middle ground: It’s Wednesday, dear readers, and you’re halfway through this latest summery week of socioeconomic innovation. Keep it up. Today is Aug. 14, and if you had the real-life, rebellious Macbeth killing his cousin, King Duncan I (in battle, not in bed), and assuming the Scottish throne on this date in 1040, glè mhath! Here’s a voucher for 100 silver sceats, redeemable in the casino. Best laid plans: To our many readers in…


‘Dormant’ biotech wakes on Alzheimer’s fast track

By GREGORY ZELLER // A pre-clinical-stage biopharmaceutical company is being fast-tracked toward a potential Alzheimer’s treatment, after taking a decidedly slow road. Stony Brook-based Avanti Biosciences Inc. actually launched in 2009, but was “dormant for a few years,” according to founder Gian Luca Araldi, “kind of an empty shell.” It was only in the last two years, when “I had some ideas I wanted to develop on my own,” that Araldi – a former senior…


A profitable pivot (sorta) for Digital Donations

By GREGORY ZELLER // They’re thinking big at Digital Donations Inc., as in Big Data. The Melville tech manufacturer has made its bones providing “alternative fundraising solutions” for nonprofit organizations, including ATM-based and point-of-sale-centered donation options. It even founded a virtual school to train charity-group founders, directors and staffers. Now, the 2014 startup is focusing its tech on for-profit customers – not abandoning its nonprofit doctrine but adding to it, according to co-founder and President…